Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome

A botulinum toxin A (BoNT-A) intravesical injection can improve the symptoms of interstitial cystitis/bladder pain syndrome (IC/BPS). Patients with IC/BPS have different clinical characteristics, urodynamic features, and cystoscopic findings. This study assessed the treatment outcomes of a BoNT-A in...

Full description

Bibliographic Details
Main Authors: Hsiu-Jen Wang, Wan-Ru Yu, Hueih-Ling Ong, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Toxins
Subjects:
bladder pain
botulinum toxin a
predictor
maximal bladder capacity
hydrodistention
Online Access:https://www.mdpi.com/2072-6651/11/11/676

Internet

https://www.mdpi.com/2072-6651/11/11/676

Similar Items